Skip to main content
https://pbs.twimg.com/media/EmT1rJ0WMAIl3S6.jpg
SELECT-PsA1 results UPA showed improvements in PROs vs PBO at 12 weeks in biologic DMARD-naïve patients w/ active PsA, which were maintained or further improved at Week 24. #ABS1341 #ACR20 @RheumNow https://t.co/q5tYItFb6g https://t.co/4QilMDBaXc
Dr. Rachel Tate
08-11-2020
×